Pilot Study on Concurrent Cisplatin-based Chemotherapy Combined With Vaccination Therapy With the P16_37-63 Peptide in Patients With HPV- and p16INK4a-positive Cancer

Trial Profile

Pilot Study on Concurrent Cisplatin-based Chemotherapy Combined With Vaccination Therapy With the P16_37-63 Peptide in Patients With HPV- and p16INK4a-positive Cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Human papillomavirus vaccine (Primary)
  • Indications Human papillomavirus infections
  • Focus Pharmacodynamics
  • Acronyms VICORYX-2
  • Sponsors Oryx GmbH & Co
  • Most Recent Events

    • 30 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 28 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 31 Mar 2016 Planned End Date changed from 1 Mar 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top